JW Pharmaceutical Corporation

KSE 001060.KS

JW Pharmaceutical Corporation Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -31.63 M

JW Pharmaceutical Corporation Net Cash Used Provided By Financing Activities is USD -31.63 M for the year ending December 31, 2023, a -8.50% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

JW Pharmaceutical Corporation Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -29.16 M, a -228.06% change year over year.
JW Pharmaceutical Corporation Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 22.77 M, a 277.03% change year over year.
JW Pharmaceutical Corporation Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -12.86 M, a 38.25% change year over year.
JW Pharmaceutical Corporation Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -20.83 M, a 43.44% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

KSE: 001060.KS

JW Pharmaceutical Corporation

CEO	Mr. Young-Sub Shin
IPO Date	Sept. 29, 2005
Location	South Korea
Headquarters	2477, Nambusunhwan-ro
Employees	1,064
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care

Description

JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years